• 1
    Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, Zahurak ML, Daniel RW, Viglione M, Symer DE, Shah KV, Sidransky D. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000; 92: 70920.
  • 2
    Van Houten VMM, Snijders PJF, van den Brekel MWM, Kummer JA, Meijer CJLM, van Leeuwen B, Denkers F, Smeele LE, Snow GB, Brakenhoff RH. Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas. Int J Cancer 2001; 93: 2325.
  • 3
    Ringström E, Peters E, Hasegawa M, Posner M, Liu M, Kelsey KT. Human papillomavirus type 16 and squamous cell carcinoma of the head and neck. Clin Cancer Res 2002; 8: 318792.
  • 4
    Wong M, Pagano JS, Schiller JT, Tevethia SS, Raab-Traub N, Gruber J. New associations of human papillomavirus, simian virus 40, and Epstein-Barr virus with human cancer. J Natl Cancer Inst 2002; 94: 18326.
  • 5
    Syrjänen KJ. HPV infections and esophageal cancer. J Clin Pathol 2002; 55: 7218.
  • 6
    Snijders PJ, Scholes AG, Hart CA, Jones AS, Vaughan ED, Woolgar JA, Meijer CJLM, Walboomers JMM, Field JK. Prevalence of mucosotropic human papillomaviruses in squamous-cell carcinoma of the head and neck. Int J Cancer 1996; 66: 4649.
  • 7
    McKaig RG, Baric RS, Olshan AF. Human papillomavirus and head and neck cancer: epidemiology and molecular biology. Head Neck 1998; 20: 25065.
  • 8
    Franceschi S, Munoz N, Snijders PJF. How strong and how wide is the link between HPV and oropharyngeal cancer? Lancet 2000; 356: 8712.
  • 9
    Ritchie JM, Smith EM, Summersgill KF, Hoffman HT, Wang D, Klussmann JP, Turek LP, Haugen TH. Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx. Int J Cancer 2003; 104: 33644.
  • 10
    Ishibashi T, Matsushima S, Tsunokawa Y, Asai M, Nomura Y, Sugimura T, Terada M. Human papillomavirus DNA in squamous cell carcinoma of the upper aerodigestive tract. Arch Otolaryngol Head Neck Surg 1990; 116: 2948.
  • 11
    Snijders PJ, Cromme FV, van den Brule AJ, Schrijnemakers HF, Snow GB, Meijer CJ, Walboomers JM. Prevalence and expression of human papillomavirus in tonsillar carcinomas, indicating a possible viral etiology. Int J Cancer 1992; 51: 84550.
  • 12
    Klussmann JP, Weissenborn SJ, Wieland U, Dries V, Kolligs J, Jungehuelsing M, Eckel HE, Dienes HP, Pfister HJ, Fuchs PG. Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas. Cancer 2001; 92: 287584.
  • 13
    Mellin H, Dahlgren L, Munck-Wikland E, Lindholm J, Rabbani H, Kalantari M, Dalianis T. Human papillomavirus type 16 is episomal and a high viral load may be correlated to better prognosis in tonsillar cancer. Int J Cancer 2002; 102: 1528.
  • 14
    Strome SE, Savva A, Brisset AE, Gostout BS, Lewis J, Clayton AC, McGovern R, Weaver AL, Persing D, Kasperbauer JL. Squamous cell carcinoma of the tonsils: a molecular analysis of HPV associations. Clin Cancer Res 2002; 8: 1093100.
  • 15
    He D, Zhang DK, Lam KY, Ma L, Ngan HY, Liu SS, Tsao SW. Prevalence of HPV infection in esophageal squamous cell carcinoma in Chinese patients and its relationship to the p53 gene mutation. Int J Cancer 1997; 72: 95964.
  • 16
    Lam KY, He D, Ma L, et al. Presence of human papillomavirus in esophageal squamous cell carcinomas of Hong Kong Chinese in its relationship with p53 gene mutation. Hum Pathol 1997; 28: 65763.
  • 17
    Miller BA, Davidson M, Myerson D, Icenogle J, Lanier AP, Tan J, Beckmann AM. Human papillomavirus type 16 DNA in esophageal carcinomas from Alaska Natives. Int J Cancer 1997; 71: 21822.
  • 18
    Mizobuchi S, Sakamoto H, Tachimori Y, Kato H, Watanabe H, Terada M. Absence of human papillomavirus-16 and -18 DNA and Epstein-Barr virus DNA in esophageal squamous cell carcinoma. Jpn J Clin Oncol 1997; 27: 15.
  • 19
    Morgan RJ, Perry AC, Newcomb PV, Hardwick RH, Alderson D. Human papillomavirus and esophageal squamous cell carcinoma in the UK. Eur J Surg Oncol 1997; 23: 5137.
  • 20
    Rugge M, Bovo D, Busatto G, Parenti AR, Fawzy S, Guido M, Ancona E, Ninfo V, Ruol A, Shiao YH. P53 alterations but no human papillomavirus infection in preinvasive and advanced squamous esophageal cancer in Italy. Cancer Epidemiol Biomarkers Prev 1997; 6: 1716.
  • 21
    Turner JR, Shen LH, Crum CP, Dean PJ, Odze RD. Low prevalence of human papillomavirus infection in esophageal squamous cell carcinomas from North America: analysis by a highly sensitive and specific polymerase chain reaction-based approach. Hum Pathol 1997; 28: 1748.
  • 22
    Takahashi A, Ogoshi S, Ono H, Ishikawa T, Toki T, Ohmori N, Iwasa M, Iwasa Y, Furihata M, Ohtsuki Y. High-risk human papillomavirus infection and overexpression of p53 protein in squamous cell carcinoma of the esophagus from Japan. Dis Esophagus 1998; 11: 1627.
  • 23
    Chang F, Syrjänen S, Shen Q, Cintorino M, Santopietro R, Tosi P, Syrjanen. Evaluation of HPV, CMV, HSV and EBV in esophageal squamous cell carcinomas from a high-incidence area of China. Anticancer Res 2000; 20: 393540.
  • 24
    Lambot MA, Haot J, Peny MO, Fayt I, Noel JC. Evaluation of the role of human papillomavirus in esophageal squamous cell carcinoma in Belgium. Acta Gastroenterol Belg 2000; 63: 1546.
  • 25
    Kawaguchi H, Ohno S, Araki K, Miyazaki M, Saeki H, Watanabe M, Tanaka S, Sugimachi K. p53 polymorphism in human papillomavirus-associated esophageal cancer. Cancer Res 2000; 60: 27535.
  • 26
    Astori G, Merluzzi S, Arzese A, Brosolo P, de Pretis G, Maieron R, Pipan C, Botta GA. Detection of human papillomavirus DNA and p53 gene mutations in esophageal cancer samples and adjacent normal mucosa. Digestion 2001; 64: 914.
  • 27
    Shen Z, Hu S, Lu L, Tang CZ, Kuang ZS, Zhong SP, Zeng Y. Detection of human papillomavirus in esophageal carcinoma. J Med Virol 2002; 68: 4126.
  • 28
    Togawa K, Jaskiewicz K, Takahashi H, Meltzer SJ, Rustgi AK. Human papillomavirus DNA sequences in esophagus squamous cell carcinoma. Gastroenterology 1994; 107: 12836.
  • 29
    West AB, Soloway GN, Lizarraga G, Tyrrell L, Longley JB. Type 73 human papillomavirus in esophageal squamous cell carcinoma: a novel association. Cancer 1996; 77: 24404.
  • 30
    de Villiers EM, Lavergne D, Chang F, Syrjanen K, Tosi P, Cintorino M, Santopietro R, Syrjanen S. An interlaboratory study to determine the presence of human papillomavirus DNA in esophageal carcinoma from China. Int J Cancer 1999; 81258.
  • 31
    Lavergne D, de Villiers E-M. Papillomavirus in esophageal papillomas and carcinomas. Int J Cancer 1999; 80: 6814.
  • 32
    Matsha T, Erasmus R, Kafuko AB, Mugwanya D, Stepien A, Parker MI. Human papillomavirus associated with esophageal cancer. J Clin Pathol 2002; 55: 58790.
  • 33
    Horiuchi M, Makuuchi H, Machimura T, et al. Survival benefit of screening for early oesophageal carcinoma in head and neck cancer patients. Dig Endosc 1998; 10: 1105.
  • 34
    Scherübl H, von Lampe B, Faiss S, Daubler P, Bohlmann P, Plath T, Foss HD, Scherer H, Strunz A, Hoffmeister B, Stein H, Zeitz M, Riecken EO. Screening for esophageal neoplasia in patients with head and neck cancer. Br J Cancer 2002; 86: 23943.
  • 35
    Greer CE, Peterson SL, Kiviat NB, Manos MM. PCR amplification from paraffin-embedded tissues. Am J Clin Pathol 1991; 95: 11724.
  • 36
    de Roda Husman AM, Walboomers JM, van den Brule AJ, Meijer CJ, Snijders PJ. The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 1995; 76: 105762.
  • 37
    Berkhout RJM, Tieben LM, Smits HL, Bavinck JN, Vermeer BJ, ter Schegget J. Nested PCR approach for detection and typing of epidermodysplasia verruciformis-associated human papillomavirus types in cutaneous cancers from renal transplant recipients. J Clin Microbiol 1995; 33: 6905.
  • 38
    de Villiers E-M, Lavergne D, McLaren K, Benton EC. Prevailing papillomavirus types in nonmelanoma carcinomas of the skin in renal allograft recipients. Int J Cancer 1997; 73: 35661.
  • 39
    Forslund O, Antonsson A, Nordin P, Stenquist B, Hansson BG. A broad range of human papillomavirus types detected with a general PCR method suitable for analysis of cutaneous tumours and normal skin. J Gen Virol 1999; 80: 243743.
  • 40
    zur Hausen H. Papillomavirus infections—a major cause of human cancers. Biochim Biophys Acta 1996; 1288: F55F78.
  • 41
    zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002; 2: 34250.
  • 42
    Bray I, Brennan P, Boffetta P. Projections of alcohol- and tobacco-related cancer mortality in Central Europe. Int J Cancer 2000; 87: 1228.
  • 43
    Kuper H, Boffetta P, Adami HO. Tobacco use and cancer causation: association by tumour type. J Intern Med 2002; 252: 20624.
  • 44
    Menzo S, Monachetti A, Trozzi C, et al. Identification of six putative novel human papillomaviruses (HPV) and characterization of candidate HPV type 87. J Virol 2001; 75: 119139.
  • 45
    de Villiers EM. Human papillomavirus infections in skin cancers. Biomed Pharmacother 1998; 52: 2633.
  • 46
    Makuuchi H, Machimura T, Shimada H, et al. Endoscopic screening for oesophageal cancer in 788 patients with head and neck cancers. Tokai Exp Clin Med 1996; 21: 13945.
  • 47
    Scherübl H, Scherer H, Hoffmeister B. Second esophageal cancers in head and neck cancer patients. N Engl J Med 2002; 346: 14167.
  • 48
    Califano J, Leong PL, Koch WM, Eisenberger CF, Sidransky D, Westra WH. Second esophageal tumor in patients with head and neck squamous cell carcinoma: an assessment of clonal relationships. Clin Cancer Res 1999; 5: 18627.